1. Home
  2. CVCO vs TVTX Comparison

CVCO vs TVTX Comparison

Compare CVCO & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CVCO

Cavco Industries Inc. When Issued

N/A

Current Price

$605.82

Market Cap

4.8B

ML Signal

N/A

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

N/A

Current Price

$50.41

Market Cap

4.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CVCO
TVTX
Founded
1965
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.7B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
CVCO
TVTX
Price
$605.82
$50.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
15
Target Price
★ $662.00
$75.21
AVG Volume (30 Days)
75.6K
★ 1.8M
Earning Date
10-29-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
15.79
★ 92.89
EPS
★ 5.43
N/A
Revenue
★ $2,142,713,000.00
N/A
Revenue This Year
$9.17
$47.49
Revenue Next Year
$7.74
$48.73
P/E Ratio
$100.27
★ N/A
Revenue Growth
★ 31.68
N/A
52 Week Low
$443.34
$22.59
52 Week High
$713.01
$68.73

Technical Indicators

Market Signals
Indicator
CVCO
TVTX
Relative Strength Index (RSI) 66.18 35.14
Support Level $558.79 $49.46
Resistance Level $630.48 $59.93
Average True Range (ATR) 21.27 2.20
MACD 6.65 0.21
Stochastic Oscillator 78.83 16.43

Price Performance

Historical Comparison
CVCO
TVTX

About CVCO Cavco Industries Inc. When Issued

Cavco Industries Inc designs and produces factory-built homes distributed through a network of independent and company-owned retailers, planned community operators and residential developers. It is also a producer of park model RVs, vacation cabins and Factory-built commercial structures. It operates principally in two segments: factory-built housing, which includes wholesale and retail factory-built housing operations and Financial services, which include manufactured housing consumer finance and insurance. The factory-built housing segment generates the majority of revenue from building and selling manufactured and modular homes to both wholesale customers and end consumers through company owned retail stores.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: